ODYY Quote, Financials, Valuation and Earnings

Delcath Systems, Inc. has a net margin of -- compared to Odyssey Health, Inc.'s net margin of 4.04%. Odyssey Health, Inc.'s return on equity of -- beat Delcath Systems, Inc.'s return on equity of 1.59%.

Odyssey Health, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Delcath Systems, Inc. has an analysts' consensus of $22.31 which suggests that it could grow by 116.13%. Given that Delcath Systems, Inc. has higher upside potential than Odyssey Health, Inc., analysts believe Delcath Systems, Inc. is more attractive than Odyssey Health, Inc..

Odyssey Health, Inc. has a beta of -1.302, which suggesting that the stock is 230.226% less volatile than S&P 500. In comparison Delcath Systems, Inc. has a beta of 0.410, suggesting its less volatile than the S&P 500 by 59.033%.

Odyssey Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Delcath Systems, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Odyssey Health, Inc. pays -- of its earnings as a dividend. Delcath Systems, Inc. pays out -- of its earnings as a dividend.

Odyssey Health, Inc. quarterly revenues are --, which are smaller than Delcath Systems, Inc. quarterly revenues of $20.6M. Odyssey Health, Inc.'s net income of -$483.4K is lower than Delcath Systems, Inc.'s net income of $830K. Notably, Odyssey Health, Inc.'s price-to-earnings ratio is 0.41x while Delcath Systems, Inc.'s PE ratio is 1,186.21x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Odyssey Health, Inc. is -- versus 4.92x for Delcath Systems, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

EXACT Sciences Corp. has a net margin of -- compared to Odyssey Health, Inc.'s net margin of -2.3%. Odyssey Health, Inc.'s return on equity of -- beat EXACT Sciences Corp.'s return on equity of -38%.

Odyssey Health, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand EXACT Sciences Corp. has an analysts' consensus of $104.56 which suggests that it could grow by 2.98%. Given that EXACT Sciences Corp. has higher upside potential than Odyssey Health, Inc., analysts believe EXACT Sciences Corp. is more attractive than Odyssey Health, Inc..

Odyssey Health, Inc. has a beta of -1.302, which suggesting that the stock is 230.226% less volatile than S&P 500. In comparison EXACT Sciences Corp. has a beta of 1.417, suggesting its more volatile than the S&P 500 by 41.664%.

Odyssey Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. EXACT Sciences Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Odyssey Health, Inc. pays -- of its earnings as a dividend. EXACT Sciences Corp. pays out -- of its earnings as a dividend.

Odyssey Health, Inc. quarterly revenues are --, which are smaller than EXACT Sciences Corp. quarterly revenues of $850.7M. Odyssey Health, Inc.'s net income of -$483.4K is higher than EXACT Sciences Corp.'s net income of -$19.6M. Notably, Odyssey Health, Inc.'s price-to-earnings ratio is 0.41x while EXACT Sciences Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Odyssey Health, Inc. is -- versus 6.18x for EXACT Sciences Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Illumina, Inc. has a net margin of -- compared to Odyssey Health, Inc.'s net margin of 13.85%. Odyssey Health, Inc.'s return on equity of -- beat Illumina, Inc.'s return on equity of 30.55%.

Odyssey Health, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Illumina, Inc. has an analysts' consensus of $125.28 which suggests that it could fall by -8.01%. Given that Illumina, Inc. has higher upside potential than Odyssey Health, Inc., analysts believe Illumina, Inc. is more attractive than Odyssey Health, Inc..

Odyssey Health, Inc. has a beta of -1.302, which suggesting that the stock is 230.226% less volatile than S&P 500. In comparison Illumina, Inc. has a beta of 1.438, suggesting its more volatile than the S&P 500 by 43.845%.

Odyssey Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Illumina, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Odyssey Health, Inc. pays -- of its earnings as a dividend. Illumina, Inc. pays out -- of its earnings as a dividend.

Odyssey Health, Inc. quarterly revenues are --, which are smaller than Illumina, Inc. quarterly revenues of $1.1B. Odyssey Health, Inc.'s net income of -$483.4K is lower than Illumina, Inc.'s net income of $150M. Notably, Odyssey Health, Inc.'s price-to-earnings ratio is 0.41x while Illumina, Inc.'s PE ratio is 30.51x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Odyssey Health, Inc. is -- versus 5.01x for Illumina, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Star Operating Cos., Inc. has a net margin of -- compared to Odyssey Health, Inc.'s net margin of 14.56%. Odyssey Health, Inc.'s return on equity of -- beat Star Operating Cos., Inc.'s return on equity of -3.67%.

Odyssey Health, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Star Operating Cos., Inc. has an analysts' consensus of $12.00 which suggests that it could grow by 10.09%. Given that Star Operating Cos., Inc. has higher upside potential than Odyssey Health, Inc., analysts believe Star Operating Cos., Inc. is more attractive than Odyssey Health, Inc..

Odyssey Health, Inc. has a beta of -1.302, which suggesting that the stock is 230.226% less volatile than S&P 500. In comparison Star Operating Cos., Inc. has a beta of 2.714, suggesting its more volatile than the S&P 500 by 171.399%.

Odyssey Health, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Star Operating Cos., Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Odyssey Health, Inc. pays -- of its earnings as a dividend. Star Operating Cos., Inc. pays out 19.54% of its earnings as a dividend. Star Operating Cos., Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Odyssey Health, Inc. quarterly revenues are --, which are smaller than Star Operating Cos., Inc. quarterly revenues of $23.7M. Odyssey Health, Inc.'s net income of -$483.4K is lower than Star Operating Cos., Inc.'s net income of $3.5M. Notably, Odyssey Health, Inc.'s price-to-earnings ratio is 0.41x while Star Operating Cos., Inc.'s PE ratio is 0.75x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Odyssey Health, Inc. is -- versus 0.52x for Star Operating Cos., Inc.. Usually stocks with elevated PS ratios are considered overvalued.